Is Anti-HBs a Useful, Economic and Neglected Tool in the Hands of Hepatologist? A meta-analysis of Observational Studies of HBv past Infection Reactivation in Patients with Lymphoma

Reactivation of HBV is a well-recognized complication following immunosuppression, also in past HBV infection. Based on scientific literature, antiHBs status in HBsAg negative/anti HBc positive patients undergoing chemotherapy may reduce the risk for HBV reactivation, so antiHBs status should be included in a management alghorithm in patients with past HBV infection prior to starting immunosuppressive therapy.